Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2025)

Serina Therapeutics' (SER) quarterly Exchange Rate Effect came in at -$12000.0 in Q4 2025, down 500.0% quarter-over-quarter from -$2000.0 in Q3 2025.

Analysis

Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2025) Analysis & Trends

Serina Therapeutics has disclosed Exchange Rate Effect across 4 years of filings, most recently posting -$12000.0 for Q4 2025.

In Q4 2025, Exchange Rate Effect changed N/A year-over-year to -$12000.0; the TTM figure through Dec 2025 stood at -$16000.0 (down 900.0% YoY), while the FY2025 annual figure was -$14000.0, changed N/A from the prior year.
Exchange Rate Effect came in at -$12000.0 for Q4 2025 at Serina Therapeutics, down from -$2000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of -$2000.0 in Q3 2025 to a low of -$12000.0 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Exchange Rate Effect (Qtr)
1	Amgen	206.44 Bn	192.45 Bn	7.24 Bn	-
2	Gilead Sciences	179.97 Bn	176.79 Bn	6.22 Bn	-19.00 Mn
3	Vertex Pharmaceuticals	130.57 Bn	122.72 Bn	2.84 Bn	-3.70 Mn
4	Regeneron Pharmaceuticals	81.63 Bn	73.63 Bn	3.93 Bn	-300,000.00
5	Argenx Se	60.34 Bn	55.16 Bn	1.37 Bn	-
6	Moderna	54.37 Bn	49.23 Bn	52.00 Mn	-2.00 Mn
7	Alnylam Pharmaceuticals	33.07 Bn	29.76 Bn	992.69 Mn	-2.45 Mn
8	Biogen	31.84 Bn	30.55 Bn	1.96 Bn	-3.40 Mn
9	Roivant Sciences	29.49 Bn	29.49 Bn	1.16 Mn	315,000.00
10	Serina Therapeutics	40.47 Mn	17.45 Mn	-	-

Historic Data

Download Data